American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2134)
  2. Solid Tumor Oncology Division (1785)
  3. GSK Faculty (1633)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (779)
  6. Department of Pathology and Laboratory Medicine (721)
  7. Human Oncology and Pathogenesis Program (682)
  8. Surgery (644)
  9. Breast Medicine Service (610)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (581)
Search Within
Formats
  1. Journal Article (2033)
  2. Meeting Abstract (1999)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2134)
  2. Solid Tumor Oncology Division (1785)
  3. GSK Faculty (1633)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (779)
  6. Department of Pathology and Laboratory Medicine (721)

More Groups

People
  1. David Solit (175)
  2. Marc Ladanyi (157)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (37)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2703)
  2. Clinical Cancer Research (1432)

Results (4135)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma
    Journal Article

    Ecker, B. L.; Tao, A. J.; Janssen, Q. P.; Walch, H. S.; Court, C. M.; Balachandran, V. P.; Crane, C. H.; D'Angelica, M. I.; Drebin, J. A.; Kingham, T. P.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Scratching the surface: NECTIN-4 as a surrogate for enfortumab vedotin resistance
    Editorial

    Aggen, D. H.; Chu, C. E.; Rosenberg, J. E.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Event-free survival as a surrogate for overall survival in gastric and gastroesophageal junction adenocarcinoma: A meta-analysis in the neoadjuvant ± adjuvant setting
    Review

    Wainberg, Z. A.; Xie, J.; Valderrama, A.; Yin, L.; Zhang, S.; Shih, C. S.; Bhagia, P.; Gu, Q.; Shitara, K.; Janjigian, Y. Y.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Randomized phase II trial of sunitinib or cediranib in alveolar soft part sarcoma
    Editorial

    Nguyen, J.; Takebe, N.; Kummar, S.; Razak, A.; Chawla, S. P.; George, S.; Patel, S. R.; Keohan, M. L.; Movva, S.; O'Sullivan Coyne, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax
    Journal Article

    Satta, T.; Li, L.; Chalasani, S. L.; Hu, X.; Nkwocha, J.; Sharma, K.; Kmieciak, M.; Rahmani, M.; Zhou, L.; Grant, S.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Mutated HRAS activates YAP1-AXL signaling to drive metastasis of head and neck cancer
    Journal Article

    Jagadeeshan, S.; Prasad, M.; Badarni, M.; Ben-Lulu, T.; Liju, V. B.; Mathukkada, S.; Saunders, C.; Shnerb, A. B.; Zorea, J.; Yegodayev, K. M.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Bolus versus continuous intravenous delivery of doxorubicin in soft-tissue sarcomas: Post hoc analysis of a prospective randomized trial (SARC021/TH CR-406)
    Journal Article

    Cranmer, L. D.; Lu, Y.; Heise, R. S.; Ballman, K. V.; Loggers, E. T.; Pollack, S. M.; Wagner, M. J.; Reinke, D. K.; Schöffski, P.; Tap, W. D.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Crizotinib has preclinical efficacy in Philadelphia-negative myeloproliferative neoplasms
    Journal Article

    Gurska, L. M.; Okabe, R.; Schurer, A.; Tong, M. M.; Soto, M.; Choi, D.; Ames, K.; Glushakow-Smith, S.; Montoya, A.; Tein, E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A single-arm phase II trial of sitravatinib in advanced well-differentiated/dedifferentiated liposarcoma
    Journal Article

    Ingham, M.; Lee, S.; Van Tine, B. A.; Choy, E.; Oza, J.; Doshi, S.; Ge, L.; Oppelt, P.; Cote, G.; Corgiat, B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: